1
|
Hrubec TC, Seguin RP, Xu L, Cortopassi GA, Datta S, Hanlon AL, Lozano AJ, McDonald VA, Healy CA, Anderson TC, Musse NA, Williams RT. Altered toxicological endpoints in humans from common quaternary ammonium compound disinfectant exposure. Toxicol Rep 2021; 8:646-656. [PMID: 33868951 PMCID: PMC8041661 DOI: 10.1016/j.toxrep.2021.03.006] [Citation(s) in RCA: 46] [Impact Index Per Article: 15.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2020] [Revised: 02/04/2021] [Accepted: 03/06/2021] [Indexed: 12/18/2022] Open
Abstract
Humans are frequently exposed to Quaternary Ammonium Compounds (QACs). QACs are ubiquitously used in medical settings, restaurants, and homes as cleaners and disinfectants. Despite their prevalence, nothing is known about the health effects associated with chronic low-level exposure. Chronic QAC toxicity, only recently identified in mice, resulted in developmental, reproductive, and immune dysfunction. Cell based studies indicate increased inflammation, decreased mitochondrial function, and disruption of cholesterol synthesis. If these findings translate to human toxicity, multiple physiological processes could be affected. This study tested whether QAC concentrations could be detected in the blood of 43 human volunteers, and whether QAC concentrations influenced markers of inflammation, mitochondrial function, and cholesterol synthesis. QAC concentrations were detected in 80 % of study participants. Blood QACs were associated with increase in inflammatory cytokines, decreased mitochondrial function, and disruption of cholesterol homeostasis in a dose dependent manner. This is the first study to measure QACs in human blood, and also the first to demonstrate statistically significant relationships between blood QAC and meaningful health related biomarkers. Additionally, the results are timely in light of the increased QAC disinfectant exposure occurring due to the SARS-CoV-2 pandemic. MAIN FINDINGS This study found that 80 % of study participants contained QACs in their blood; and that markers of inflammation, mitochondrial function, and sterol homeostasis varied with blood QAC concentration.
Collapse
Key Words
- 7-DHC, 7-Dehydrocholesterol
- 7-DHD, 7-Dehydrodesmosterol
- 8-DHC, 8-Dehydrocholesterol
- ADBAC, alkyldimethylbenzyl ammonium chloride
- ANOVA, analysis of variance
- BAC, benzalkonium chloride
- CRP, C-reactive protein
- DDAC, didecyldimethyl ammonium chloride
- Environmental toxicology
- FCCP, trifluoromethoxy carbonylcyanide phenylhydrazone
- IL-10, interleukin 10
- IL-12, interleukin 12
- IL-6, interleukin 6
- IRB, Institutional Review Board
- Inflammation
- LC, liquid chromatography
- LOD, level of detection
- LOQ, level of quantification
- LPS, lipopolysaccharide
- Lipid metabolism
- Mitochondrial function
- NF-κB, nuclear factor kappa beta
- NOEL, no effect level
- OCR, oxygen consumption rate
- OEL, occupational exposure limit
- QAC, quaternary ammonium compounds
- Quaternary ammonium compounds
- TNFα, tumor necrosis factor alpha
Collapse
Affiliation(s)
- Terry C. Hrubec
- Department of Biomedical Science, E. Via College of Osteopathic Medicine – Virginia, Blacksburg, VA, 24060, USA
- Department of Biomedical Science and Pathobiology, VA-MD College of Veterinary Medicine, Virginia Tech, Blacksburg, VA, 24061, USA
| | - Ryan P. Seguin
- Department of Medicinal Chemistry, School of Pharmacy, University of Washington, Seattle, WA, 98195, USA
| | - Libin Xu
- Department of Medicinal Chemistry, School of Pharmacy, University of Washington, Seattle, WA, 98195, USA
| | - Gino A. Cortopassi
- Department of Molecular Biosciences, School of Veterinary Medicine, University of California – Davis, Davis, CA, 95618, USA
| | - Sandipan Datta
- Department of Molecular Biosciences, School of Veterinary Medicine, University of California – Davis, Davis, CA, 95618, USA
| | - Alexandra L. Hanlon
- Center for Biostatistics and Health Data Science, Department of Statistics, College of Science, Virginia Tech, Riverside Circle, Roanoke, VA, 24016, USA
| | - Alicia J. Lozano
- Center for Biostatistics and Health Data Science, Department of Statistics, College of Science, Virginia Tech, Riverside Circle, Roanoke, VA, 24016, USA
| | - Valerie A. McDonald
- Department of Biomedical Science, E. Via College of Osteopathic Medicine – Virginia, Blacksburg, VA, 24060, USA
| | - Claire A. Healy
- Department of Biomedical Science, E. Via College of Osteopathic Medicine – Virginia, Blacksburg, VA, 24060, USA
| | - Tyler C. Anderson
- Department of Biomedical Science, E. Via College of Osteopathic Medicine – Virginia, Blacksburg, VA, 24060, USA
| | - Najaha A. Musse
- Department of Biomedical Science, E. Via College of Osteopathic Medicine – Virginia, Blacksburg, VA, 24060, USA
| | - Richard T. Williams
- Department of Biomedical Science, E. Via College of Osteopathic Medicine – Virginia, Blacksburg, VA, 24060, USA
| |
Collapse
|
2
|
Karasawa T, Kawashima A, Usui F, Kimura H, Shirasuna K, Inoue Y, Komada T, Kobayashi M, Mizushina Y, Sagara J, Takahashi M. Oligomerized CARD16 promotes caspase-1 assembly and IL-1β processing. FEBS Open Bio 2015; 5:348-56. [PMID: 25973362 PMCID: PMC4420773 DOI: 10.1016/j.fob.2015.04.011] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2015] [Revised: 04/17/2015] [Accepted: 04/17/2015] [Indexed: 12/26/2022] Open
Abstract
CARD16 is the most abundant CARD-only protein in hematopoietic cells. Unlike CARD17, CARD16 oligomerizes to form a filament-like structure. The filament-like structure formed by CARD16 promotes caspase 1 (CASP1) assembly. CASP1-dependent IL-1β processing is enhanced by CARD16. CARD16 colocalizes in ASC-speck by interacting with ASC.
Increasing evidence indicates that caspase recruitment domain (CARD)-mediated caspase-1 (CASP1) assembly is an essential process for its activation and subsequent interleukin (IL)-1β release, leading to the initiation of inflammation. Both CARD16 and CARD17 were previously reported as inhibitory homologs of CASP1; however, their molecular function remains unclear. Here, we identified that oligomerization activity allows CARD16 to function as a CASP1 activator. We investigated the molecular characteristics of CARD16 and CARD17 in transiently transfected HeLa cells. Although both CARD16 and CARD17 interacted with CASP1CARD, only CARD16 formed a homo-oligomer. Oligomerized CARD16 formed a filament-like structure with CASP1CARD and a speck with apoptosis-associated speck-like protein containing a CARD. A filament-like structure formed by CARD16 promoted CASP1 filament assembly and IL-1β release. In contrast, CARD17 did not form a homo-oligomer or filaments and inhibited CASP1-dependent IL-1β release. Mutated CARD16D27G, mimicking the CARD17 amino acid sequence, formed a homo-oligomer but failed to form a filament-like structure. Consequently, CARD16D27G weakly promoted CASP1 filament assembly and subsequent IL-1β release. These results suggest that oligomerized CARD16 promotes CARD-mediated molecular assembly and CASP1 activation.
Collapse
Key Words
- ANOVA, analysis of variance
- ASC, apoptosis-associated speck-like protein containing a caspase recruitment domain
- BS3, bis(sulfosccinimidyl)suberate
- Bcl10, B-cell lymphoma/leukemia 10
- CARD, caspase recruitment domain
- CARMA1, CARD-membrane-associated guanylate kinase 1
- CASP1, caspase-1
- COPs, CARD-only proteins
- Caspase
- Cytokine
- ELISA, enzyme-linked immunosorbent assay
- FCS, fetal calf serum
- IL, interleukin
- Inflammation
- Interleukin
- LPS, lipopolysaccharide
- LRRs, leucine-rich repeats
- NF-κB, nuclear factor kappa beta
- NLRs, nucleotide-binding domain leucine-rich repeat containing receptors
- PYD, pyrin domain
Collapse
Affiliation(s)
- Tadayoshi Karasawa
- Division of Inflammation Research, Center for Molecular Medicine, Jichi Medical University, Tochigi, Japan
- Corresponding authors at: Division of Inflammation Research, Center for Molecular Medicine, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi 329-0498, Japan. Tel.: +81 285 58 7446; fax: +81 285 44 5365.
| | - Akira Kawashima
- Division of Inflammation Research, Center for Molecular Medicine, Jichi Medical University, Tochigi, Japan
| | - Fumitake Usui
- Division of Inflammation Research, Center for Molecular Medicine, Jichi Medical University, Tochigi, Japan
| | - Hiroaki Kimura
- Division of Inflammation Research, Center for Molecular Medicine, Jichi Medical University, Tochigi, Japan
| | - Koumei Shirasuna
- Division of Inflammation Research, Center for Molecular Medicine, Jichi Medical University, Tochigi, Japan
| | - Yoshiyuki Inoue
- Division of Inflammation Research, Center for Molecular Medicine, Jichi Medical University, Tochigi, Japan
| | - Takanori Komada
- Division of Inflammation Research, Center for Molecular Medicine, Jichi Medical University, Tochigi, Japan
| | - Motoi Kobayashi
- Division of Inflammation Research, Center for Molecular Medicine, Jichi Medical University, Tochigi, Japan
| | - Yoshiko Mizushina
- Division of Inflammation Research, Center for Molecular Medicine, Jichi Medical University, Tochigi, Japan
| | - Junji Sagara
- Department of Molecular Oncology, Shinshu University Graduate School of Medicine, Nagano, Japan
| | - Masafumi Takahashi
- Division of Inflammation Research, Center for Molecular Medicine, Jichi Medical University, Tochigi, Japan
- Corresponding authors at: Division of Inflammation Research, Center for Molecular Medicine, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi 329-0498, Japan. Tel.: +81 285 58 7446; fax: +81 285 44 5365.
| |
Collapse
|